Cell Therapy Insights from KOL Investigators & CRO Researchers
Access On-Demand Recording
Join us for a Precision for Medicine Investigator Insights webinar co-hosted by Roswell Park Comprehensive Cancer Center. You will hear from 2 leading investigators on the lessons learned, current trends, and insights relevant to the cell therapy community. Dr. Renier Brentjens (Roswell Park) and Dr. Pawel Kalinski (Roswell Park) have collectively published >250 papers, and both have been recognized for excellence in cell therapy research. This is a rare opportunity to gain insight on CAR-T and Dendritic Cell Therapy from 2 leading experts.
The webinar will consist of a 45- to 50-minute panel discussion followed by a live 15- to 10-minute Q&A session with the audience.
Topics covered:
- Lessons learned to support study planning
- Lessons learned to support study execution
- General discussion around cell therapy and cancer targets
Webinar Speakers
Renier Brentjens MD, Ph.D.
Professor of Oncology,
Roswell Park
Pawel Kalinski MD, Ph.D.
Chief Translational Immuno-Oncology & SVP Team Science, Roswell Park
Etleva Pashaj, MD
Vice President,
Precision for Medicine
Cell & Gene Tx Overview
Our experience developing multiple types of cellular therapies gives us the understanding to develop bespoke solutions for each therapeutic cell type including CAR T cells, stem cells, & tumor-infiltrating lymphocytes.
Cell & Gene TX Manufacturing
Through our partnerships with the pioneers of cell and gene therapy, we have developed best practices that speed product to market—and built the largest advanced therapy manufacturing footprint in the world.
Oncology-Hematology Overview
Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.
